ADASTRA HOLDINGS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.19 CAD | 0.00% |
|
-13.64% | -13.64% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 13.3 18.27 | Sales 2023 | 22.22 30.54 | Capitalization | 12.31M 16.92M |
|---|---|---|---|---|---|
| Net income 2022 | -4M -5.5M | Net income 2023 | -3M -4.12M | EV / Sales 2022 | 1,272,975 x |
| Net Debt 2022 | 2.93M 4.03M | Net Debt 2023 | 2.26M 3.11M | EV / Sales 2023 | 655,990 x |
| P/E ratio 2022 |
-3.46
x | P/E ratio 2023 |
-3.47
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.72% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -2.56% | ||
| 1 week | -13.64% | ||
| Current month | -13.64% | ||
| 1 month | -26.92% | ||
| 3 months | -2.56% | ||
| 6 months | -22.45% | ||
| Current year | -13.64% |
1 week
0.19
0.23
1 month
0.180.26
Current year
0.170.29
1 year
0.170.49
3 years
0.112.00
5 years
0.112.97
10 years
0.112.97
| Managers | Title | Age | Since |
|---|---|---|---|
Lachlan McLeod
CEO | Chief Executive Officer | 37 | 23-02-13 |
Andrew Hale
FOU | Founder | - | 89-07-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Andrew Hale
FOU | Founder | - | 89-07-30 |
Paul Morgan
BRD | Director/Board Member | - | 21-07-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 0.19 | -2.56% | 2,004 |
| 24-05-06 | 0.195 | -11.36% | 11,410 |
| 24-05-03 | 0.22 | +12.82% | 1,246 |
| 24-05-01 | 0.195 | -11.36% | 13,096 |
| 24-04-30 | 0.22 | +4.76% | 3,250 |
Delayed Quote Canadian Securities Exchange, May 07, 2024 at 02:01 pm EDT
More quotes
Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products. The Company serves medical markets and is engaged in therapeutic applications. The Companyâs Phyto Extractions and Endgame Extracts brands distribute cannabis concentrate products through retailers at approximately 2,000 locations across Canada. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. It partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., Chemia Analytics Inc., 1225140 B.C. Ltd and 1204581 B.C. Ltd.
Sector
Pharmaceuticals
Calendar
2024-05-27
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.64% | 7.99M | |
| +43.96% | 6.32B | |
| -15.56% | 4.49B | |
| -6.52% | 3.3B | |
| +5.47% | 3.19B | |
| -0.76% | 2.6B | |
| +56.34% | 2.05B | |
| -4.11% | 1.77B | |
| +2.93% | 1.7B | |
| -8.02% | 1.63B |
- Stock Market
- Equities
- XTRX Stock